1. Division of Pathological Sciences; Department of Pharmacology and Experimental Therapeutics; Kyoto Pharmaceutical University; Kyoto Japan
2. Second Department of Internal Medicine; Osaka Medical College; Takatsuki Osaka Japan
3. R&D Center; Biofermin Pharmaceutical Co., Ltd.; Kobe Hyogo Japan